Get started
CHENGDU EASTON BIO PHARMACEUTICALSCHENGDU EASTON BIO PHARMACEUTICALSCHENGDU EASTON BIO PHARMACEUTICALS

CHENGDU EASTON BIO PHARMACEUTICALS

No trades
See on Supercharts
Overview
Financials Discussions Technicals Forecast Seasonals

688513 chart


Full chart

Key stats


Market capitalization
‪10.68 B‬ CNY
Dividend yield (indicated)
0.71%
Price to earnings Ratio (TTM)
55.94
Basic EPS (TTM)
1.15 CNY
Net income (FY)
‪238.23 M‬ CNY
Revenue (FY)
‪1.33 B‬ CNY
Shares float
‪80.46 M‬
Beta (1Y)
1.01

Employees


Employees (FY)
‪1.52 K‬
Change (1Y)
+122 +8.71%
Revenue / Employee (1Y)
‪873.04 K‬ CNY
Net income / Employee (1Y)
‪156.53 K‬ CNY

About CHENGDU EASTON BIO PHARMACEUTICALS


Sector
Health Technology
Industry
Pharmaceuticals: Major
CEO
Ming Xu Yuan
Website
eastonpharma.cn
Headquarters
Chengdu
Founded
2009
ISIN
CNE100004397
FIGI
BBG00NSMWTC8
Chengdu Easton Bio Pharmaceuticals Co., Ltd. engages in the research, development, production, and sale of chemical raw materials and drug preparation. Its products include anti-tumor medicines such as Ubenimex capsules and ibandronate injections; cardiovascular medicines such as bisoprolol fumarate tablets; digestive medicines such as compound glycyrrhizin injections; anesthesia and analgesic products such as nalmefene hydrochloride injections and ibuprofen; and children’s medications. The company was founded by Ying Wang on June 1, 2009 and is headquartered in Chengdu, China.

Check out other big names from the same industry as 688513.

Financials


Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:—

Technicals


Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Analyst rating


An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Seasonals


Displays a symbol's price movements over previous years to identify recurring trends.

Frequently Asked Questions


The current price of 688513 is 60.50 CNY — it has decreased by −5.91% in the past 24 hours. Watch CHENGDU EASTON BIO PHARMACEUTICALS stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on SSE exchange CHENGDU EASTON BIO PHARMACEUTICALS stocks are traded under the ticker 688513.
688513 stock has risen by 16.55% compared to the previous week, the month change is a 40.70% rise, over the last year CHENGDU EASTON BIO PHARMACEUTICALS has showed a 94.78% increase.
We've gathered analysts' opinions on CHENGDU EASTON BIO PHARMACEUTICALS future price: according to them, 688513 price has a max estimate of 43.00 CNY and a min estimate of 43.00 CNY. Watch 688513 chart and read a more detailed CHENGDU EASTON BIO PHARMACEUTICALS stock forecast: see what analysts think of CHENGDU EASTON BIO PHARMACEUTICALS and suggest that you do with its stocks.
688513 reached its all-time high on Jul 29, 2025 with the price of 68.52 CNY, and its all-time low was 28.11 CNY and was reached on Jul 30, 2024. View more price dynamics on 688513 chart.
See other stocks reaching their highest and lowest prices.
688513 stock is 12.17% volatile and has beta coefficient of 1.01. Track CHENGDU EASTON BIO PHARMACEUTICALS stock price on the chart and check out the list of the most volatile stocks — is CHENGDU EASTON BIO PHARMACEUTICALS there?
Today CHENGDU EASTON BIO PHARMACEUTICALS has the market capitalization of ‪10.52 B‬, it has increased by 6.44% over the last week.
Yes, you can track CHENGDU EASTON BIO PHARMACEUTICALS financials in yearly and quarterly reports right on TradingView.
688513 net income for the last quarter is ‪60.59 M‬ CNY, while the quarter before that showed ‪21.21 M‬ CNY of net income which accounts for 185.66% change. Track more CHENGDU EASTON BIO PHARMACEUTICALS financial stats to get the full picture.
Yes, 688513 dividends are paid annually. The last dividend per share was 0.43 CNY. As of today, Dividend Yield (TTM)% is 0.71%. Tracking CHENGDU EASTON BIO PHARMACEUTICALS dividends might help you take more informed decisions.
CHENGDU EASTON BIO PHARMACEUTICALS dividend yield was 1.43% in 2024, and payout ratio reached 31.42%. The year before the numbers were 0.91% and 30.73% correspondingly. See high-dividend stocks and find more opportunities for your portfolio.
As of Aug 3, 2025, the company has ‪1.52 K‬ employees. See our rating of the largest employees — is CHENGDU EASTON BIO PHARMACEUTICALS on this list?
Like other stocks, 688513 shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade CHENGDU EASTON BIO PHARMACEUTICALS stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So CHENGDU EASTON BIO PHARMACEUTICALS technincal analysis shows the buy rating today, and its 1 week rating is strong buy. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating CHENGDU EASTON BIO PHARMACEUTICALS stock shows the buy signal. See more of CHENGDU EASTON BIO PHARMACEUTICALS technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.